{"abstract": "John L. LaMattina said he was leaving the company, five months after Pfizer was forced to cancel development of its highest-profile drug candidate.", "web_url": "https://www.nytimes.com/2007/05/21/business/21pfizer.html", "snippet": "John L. LaMattina said he was leaving the company, five months after Pfizer was forced to cancel development of its highest-profile drug candidate.", "lead_paragraph": "Pfizer\u2019s head of research, John L. LaMattina, said yesterday that he was leaving the company, five months after Pfizer was abruptly forced to cancel development of torcetrapib, a heart medicine that was its highest-profile drug candidate.", "print_section": "C", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer\u2019s Head of Research Is Departing", "kicker": null, "content_kicker": null, "print_headline": "Pfizer\u2019s Head Of Research Is Departing", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Executives and Management", "rank": 4, "major": "N"}], "pub_date": "2007-05-21T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Alex Berenson", "person": [{"firstname": "Alex", "middlename": null, "lastname": "Berenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/17d2e194-da98-56ee-a162-ec40115de18e", "word_count": 392, "uri": "nyt://article/17d2e194-da98-56ee-a162-ec40115de18e"}